 | CBU | Name: | (1R,2R,3S,4S,5S,6S)-CYCLOHEXANE-1,2,3,4,5,6-HEXOL | Formula: | C6 H12 O6 | SMILES: | OC1C(O)C(O)C(O)C(O)C1O | InChi: | InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4-,5+,6+/m0/s1 | Definition date: | 2008-05-03 | Last modified: | 2024-09-27 | Identifier: | (1R,2R,3S,4S,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol |
|
 | CCD | Name: | (4R)-4-HYDROXY-N,N,N-TRIMETHYLPENTAN-1-AMINIUM | Formula: | C8 H20 N O | SMILES: | OC(C)CCC[N+](C)(C)C | InChi: | InChI=1S/C8H20NO/c1-8(10)6-5-7-9(2,3)4/h8,10H,5-7H2,1-4H3/q+1/t8-/m1/s1 | Definition date: | 2006-06-15 | Last modified: | 2024-09-27 | Identifier: | (4R)-4-hydroxy-N,N,N-trimethylpentan-1-aminium |
|
 | CCS | Name: | CARBOXYMETHYLATED CYSTEINE | Formula: | C5 H9 N O4 S | SMILES: | O=C(O)C(N)CSCC(=O)O | InChi: | InChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | S-(carboxymethyl)-L-cysteine |
|
 | CCY | Name: | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5-(4-HYDROXY-BENZYL)-3-(ETHANOYL)-3,5-DIHYDRO-IMIDAZOL-4-ONE | Formula: | C14 H19 N3 O4 S | SMILES: | O=C1N(CC(=O)O)C(NC1Cc2ccc(O)cc2)C(N)CS | InChi: | InChI=1S/C14H19N3O4S/c15-10(7-22)13-16-11(14(21)17(13)6-12(19)20)5-8-1-3-9(18)4-2-8/h1-4,10-11,13,16,18,22H,5-7,15H2,(H,19,20)/t10-,11-,13-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(2S,4S)-2-[(1R)-1-amino-2-sulfanylethyl]-4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]acetic acid |
|
 | CCZ | Name: | phenyl (4-carbamimidoylbenzyl)phosphonate | Formula: | C14 H15 N2 O3 P | SMILES: | O=P(O)(Oc1ccccc1)Cc2ccc(C(=[N@H])N)cc2 | InChi: | InChI=1S/C14H15N2O3P/c15-14(16)12-8-6-11(7-9-12)10-20(17,18)19-13-4-2-1-3-5-13/h1-9H,10H2,(H3,15,16)(H,17,18) | Synonyms: | phenyl Benzamidine Phosphonate | Definition date: | 2010-07-27 | Last modified: | 2024-09-27 | Identifier: | phenyl hydrogen (R)-(4-carbamimidoylbenzyl)phosphonate |
|
 | CD6 | Name: | (2R)-5-methylidene-2-{(1R)-2-oxo-1-[(phenylacetyl)amino]ethyl}-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Formula: | C16 H16 N2 O4 S | SMILES: | O=CC(NC(=O)Cc1ccccc1)C2N=C(C(=O)O)C(=C)CS2 | InChi: | InChI=1S/C16H16N2O4S/c1-10-9-23-15(18-14(10)16(21)22)12(8-19)17-13(20)7-11-5-3-2-4-6-11/h2-6,8,12,15H,1,7,9H2,(H,17,20)(H,21,22)/t12-,15-/m1/s1 | Definition date: | 2012-01-19 | Last modified: | 2024-09-27 | Release date: | 2012-09-14 | Identifier: | (2R)-5-methylidene-2-{(1R)-2-oxo-1-[(phenylacetyl)amino]ethyl}-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CD7 | Name: | (2S,5Z)-1-formyl-5-imino-N'-[(3R)-1-(sulfooxy)pyrrolidine-3-carbonyl]piperidine-2-carbohydrazide | Formula: | C12 H19 N5 O7 S | SMILES: | O=CN1C(CCC(/C1)=N)C(NNC(=O)C2CCN(OS(=O)(=O)O)C2)=O | InChi: | InChI=1S/C12H19N5O7S/c13-9-1-2-10(16(6-9)7-18)12(20)15-14-11(19)8-3-4-17(5-8)24-25(21,22)23/h7-8,10,13H,1-6H2,(H,14,19)(H,15,20)(H,21,22,23)/b13-9-/t8-,10+/m1/s1 | Synonyms: | open form - WCK 5153 | Definition date: | 2017-09-20 | Last modified: | 2024-09-27 | Release date: | 2018-08-01 | Identifier: | (2S,5Z)-1-formyl-5-imino-N'-[(3R)-1-(sulfooxy)pyrrolidine-3-carbonyl]piperidine-2-carbohydrazide |
|
 | CD8 | Name: | (2R)-2-[(1S)-1-(benzoylamino)-1-methoxy-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Formula: | C16 H16 N2 O5 S | SMILES: | O=CC(OC)(NC(=O)c1ccccc1)C2N=C(C(=O)O)C(=C)CS2 | InChi: | InChI=1S/C16H16N2O5S/c1-10-8-24-15(17-12(10)14(21)22)16(9-19,23-2)18-13(20)11-6-4-3-5-7-11/h3-7,9,15H,1,8H2,2H3,(H,18,20)(H,21,22)/t15-,16+/m1/s1 | Definition date: | 2012-01-12 | Last modified: | 2024-09-27 | Release date: | 2012-09-14 | Identifier: | (2R)-2-[(1S)-1-(benzoylamino)-1-methoxy-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CDE | Name: | 1,2-DIMETHYL-PROPYLAMINE | Formula: | C5 H13 N | SMILES: | NC(C)C(C)C | InChi: | InChI=1S/C5H13N/c1-4(2)5(3)6/h4-5H,6H2,1-3H3/t5-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R)-3-methylbutan-2-amine |
|
 | CDS | Name: | (2R)-2-[(1R)-1-{[(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-(METHOXYIMINO)ACETYL]AMINO}-2-OXOETHYL]-5-[(Z)-2-(4-METHYL-1,3-THIAZOL-5-YL)VINYL]-3,6-DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID | Formula: | C19 H20 N6 O5 S3 | SMILES: | O=CC(NC(=O)/C(=NOC)c1nc(sc1)N)C2SCC(=C(N2)C(=O)O)/C=Cc3scnc3C | InChi: | InChI=1S/C19H20N6O5S3/c1-9-13(33-8-21-9)4-3-10-6-31-17(24-14(10)18(28)29)11(5-26)22-16(27)15(25-30-2)12-7-32-19(20)23-12/h3-5,7-8,11,17,24H,6H2,1-2H3,(H2,20,23)(H,22,27)(H,28,29)/b4-3-,25-15-/t11-,17-/m1/s1 | Definition date: | 2007-05-29 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CE7 | Name: | (3S)-3-amino-4,4,4-trihydroxybutanamide | Formula: | C4 H10 N2 O4 | SMILES: | C(C(N)=O)C(N)C(O)(O)O | InChi: | InChI=1S/C4H10N2O4/c5-2(1-3(6)7)4(8,9)10/h2,8-10H,1,5H2,(H2,6,7)/t2-/m0/s1 | Definition date: | 2017-09-20 | Last modified: | 2024-09-27 | Release date: | 2018-02-07 | Identifier: | (3S)-3-amino-4,4,4-trihydroxybutanamide |
|
 | CED | Name: | 5-METHYL-2-[2-OXO-1-(2-THIOPHEN-2-YL-ACETYLAMINO)-ETHYL]-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | Formula: | C14 H16 N2 O4 S2 | SMILES: | O=CC(NC(=O)Cc1sccc1)C2SCC(=C(C(=O)O)N2)C | InChi: | InChI=1S/C14H16N2O4S2/c1-8-7-22-13(16-12(8)14(19)20)10(6-17)15-11(18)5-9-3-2-4-21-9/h2-4,6,10,13,16H,5,7H2,1H3,(H,15,18)(H,19,20)/t10-,13-/m1/s1 | Synonyms: | DEGRADED CEPHALORIDINE, open form | Definition date: | 2000-12-20 | Last modified: | 2024-09-27 | Identifier: | (2R)-5-methyl-2-{(1R)-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CEF | Name: | CEFOTAXIME, C3' cleaved, open, bound form | Formula: | C14 H15 N5 O5 S2 | SMILES: | CON=C(C(=O)N[CH](C=O)[CH]1SCC(=C)C(=N1)C(O)=O)c2csc(N)n2 | InChi: | InChI=1S/C14H15N5O5S2/c1-6-4-25-12(18-9(6)13(22)23)7(3-20)16-11(21)10(19-24-2)8-5-26-14(15)17-8/h3,5,7,12H,1,4H2,2H3,(H2,15,17)(H,16,21)(H,22,23)/b19-10-/t7-,12-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2-[1-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-2-oxidanylidene-ethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid |
|
 | CEH | Name: | 5-{3-(S)-(4-(R)-ACETYLAMINO-4-CARBOXY-BUTYRYLAMINO)-3-[1-(R)-(1-(R)-CARBOXY-ETHYLCARBAMOYL)-ETHYLCARBAMOYL]-PROPYL}-2-(
CARBOXY-PHENYLACETYLAMINO-METHYL)-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | Formula: | C32 H42 N6 O13 S | SMILES: | O=C(O)C(NC(=O)C(NC(=O)C(NC(=O)CCC(C(=O)O)NC(=O)C)CCC1=C(NC(SC1)C(NC(=O)Cc2ccccc2)C(=O)O)C(=O)O)C)C | InChi: | InChI=1S/C32H42N6O13S/c1-15(26(42)34-16(2)29(44)45)33-27(43)20(36-22(40)12-11-21(30(46)47)35-17(3)39)10-9-19-14-52-28(38-24(19)31(48)49)25(32(50)51)37-23(41)13-18-7-5-4-6-8-18/h4-8,15-16,20-21,25,28,38H,9-14H2,1-3H3,(H,33,43)(H,34,42)(H,35,39)(H,36,40)(H,37,41)(H,44,45)(H,46,47)(H,48,49)(H,50,51)/t15-,16-,20+,21-,25+,28-/m1/s1 | Synonyms: | CEPHALOSPORIN ANALOG | Definition date: | 2001-01-09 | Last modified: | 2024-09-27 | Identifier: | N-{(2S)-2-[(N-acetyl-D-gamma-glutamyl)amino]-4-[(2R)-4-carboxy-2-{(R)-carboxy[(phenylacetyl)amino]methyl}-3,6-dihydro-2H-1,3-thiazin-5-yl]butanoyl}-D-alanyl-D-alanine |
|
 | CEM | Name: | N-(1-CARBOXY-2-HYDROXY-4-OXO-BUTYL)-N-(3-OXO-CISPROPENYL)AMINE | Formula: | C8 H11 N O5 | SMILES: | O=CCC(O)C(NC=C/C=O)C(=O)O | InChi: | InChI=1S/C8H11NO5/c10-4-1-3-9-7(8(13)14)6(12)2-5-11/h1,3-7,9,12H,2H2,(H,13,14)/b3-1-/t6-,7+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-hydroxy-5-oxo-N-[(1Z)-3-oxoprop-1-en-1-yl]-D-norvaline |
|
 | CEO | Name: | 5-METHYLENE-2-[2-OXO-1-(2-THIOPHEN-2-YL-ACETYLAMINO)-ETHYL]-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | Formula: | C14 H14 N2 O4 S2 | SMILES: | O=CC(NC(=O)Cc1sccc1)C2N=C(C(=C)CS2)C(=O)O | InChi: | InChI=1S/C14H14N2O4S2/c1-8-7-22-13(16-12(8)14(19)20)10(6-17)15-11(18)5-9-3-2-4-21-9/h2-4,6,10,13H,1,5,7H2,(H,15,18)(H,19,20)/t10-,13-/m1/s1 | Synonyms: | HYDROLYZED CEPHALOTHIN | Definition date: | 2002-02-11 | Last modified: | 2024-09-27 | Identifier: | (2R)-5-methylidene-2-{(1R)-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CEP | Name: | CEPHALOTHIN GROUP | Formula: | C16 H18 N2 O6 S2 | SMILES: | O=C(OC)CC1=C(NC(SC1)C(NC(=O)Cc2sccc2)C=O)C(=O)O | InChi: | InChI=1S/C16H18N2O6S2/c1-24-13(21)5-9-8-26-15(18-14(9)16(22)23)11(7-19)17-12(20)6-10-3-2-4-25-10/h2-4,7,11,15,18H,5-6,8H2,1H3,(H,17,20)(H,22,23)/t11-,15-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R)-5-(2-methoxy-2-oxoethyl)-2-{(1R)-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CER | Name: | (2S, 3R)-3-HYDROXY-4-OXO-7,10-TRANS,TRANS-DODECADIENAMIDE | Formula: | C12 H19 N O3 | SMILES: | O=C(N)CC(O)C(=O)CC/C=C/C/C=C/C | InChi: | InChI=1S/C12H19NO3/c1-2-3-4-5-6-7-8-10(14)11(15)9-12(13)16/h2-3,5-6,11,15H,4,7-9H2,1H3,(H2,13,16)/b3-2+,6-5+/t11-/m0/s1 | Synonyms: | CERULENIN | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3S,7E,10E)-3-hydroxy-4-oxododeca-7,10-dienamide |
|
 | CES | Name: | 2-[CARBOXY-(2-FURAN-2-YL-2-METHOXYIMINO-ACETYLAMINO)-METHYL]-5-METHYL-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | Formula: | C15 H17 N3 O7 S | SMILES: | O=C(O)C(NC(=O)/C(=NOC)c1occc1)C2SCC(=C(N2)C(=O)O)C | InChi: | InChI=1S/C15H17N3O7S/c1-7-6-26-13(17-9(7)14(20)21)11(15(22)23)16-12(19)10(18-24-2)8-4-3-5-25-8/h3-5,11,13,17H,6H2,1-2H3,(H,16,19)(H,20,21)(H,22,23)/b18-10-/t11-,13+/m0/s1 | Synonyms: | CEFUROXIME (INHIBITION FORM) | Definition date: | 1999-10-06 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-[(R)-carboxy{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}methyl]-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CEV | Name: | ethyl (4R)-4-amino-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate | Formula: | C11 H20 N2 O3 | SMILES: | O=C1NCCC1CC(N)CCC(=O)OCC | InChi: | InChI=1S/C11H20N2O3/c1-2-16-10(14)4-3-9(12)7-8-5-6-13-11(8)15/h8-9H,2-7,12H2,1H3,(H,13,15)/t8-,9+/m0/s1 | Definition date: | 2012-04-05 | Last modified: | 2024-09-27 | Identifier: | ethyl (4R)-4-amino-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate |
|
 | CF0 | Name: | fluoromethane | Formula: | C H3 F | SMILES: | FC | InChi: | InChI=1S/CH3F/c1-2/h1H3 | Synonyms: | Fluoro methyl group | Definition date: | 2009-01-06 | Last modified: | 2024-09-27 | Identifier: | fluoromethane |
|
 | CFD | Name: | (2R,3E,5R)-5-amino-2,4-dimethylhex-3-enal | Formula: | C8 H15 N O2 | SMILES: | O=CC(C=C(/C)C(N)C)C | InChi: | InChI=1S/C8H15NO2/c1-5(7(3)9)4-6(2)8(10)11/h4,6-7H,9H2,1-3H3,(H,10,11)/b5-4+/t6-,7-/m1/s1 | Definition date: | 2008-12-17 | Last modified: | 2024-09-27 | Identifier: | (2R,3E,5R)-5-amino-2,4-dimethylhex-3-enal |
|
 | CFT | Name: | TRIFLUOROMETHANE | Formula: | C H F3 | SMILES: | FC(F)F | InChi: | InChI=1S/CHF3/c2-1(3)4/h1H | Definition date: | 2003-01-31 | Last modified: | 2024-09-27 | Identifier: | trifluoromethane |
|
 | CFU | Name: | (2R)-2-[(1R)-1-(acetylamino)-2-oxoethyl]-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Formula: | C10 H14 N2 O4 S | SMILES: | O=CC(NC(=O)C)C1SCC(=C(C(=O)O)N1)C | InChi: | InChI=1S/C10H14N2O4S/c1-5-4-17-9(12-8(5)10(15)16)7(3-13)11-6(2)14/h3,7,9,12H,4H2,1-2H3,(H,11,14)(H,15,16)/t7-,9-/m1/s1 | Definition date: | 2014-09-05 | Last modified: | 2024-09-27 | Release date: | 2014-09-17 | Identifier: | (2R)-2-[(1R)-1-(acetylamino)-2-oxoethyl]-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | CFY | Name: | [(4Z)-2-{(2R)-2-[(1S)-1-amino-2-phenylethyl]-2-hydroxy-2,5-dihydro-1,3-thiazol-4-yl}-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid | Formula: | C23 H22 N4 O5 S | SMILES: | O=C(O)CN1C(=O)C(N=C1C2=NC(O)(SC2)C(N)Cc3ccccc3)=Cc4ccc(O)cc4 | InChi: | InChI=1S/C23H22N4O5S/c24-19(11-14-4-2-1-3-5-14)23(32)26-18(13-33-23)21-25-17(22(31)27(21)12-20(29)30)10-15-6-8-16(28)9-7-15/h1-10,19,28,32H,11-13,24H2,(H,29,30)/b17-10-/t19-,23+/m0/s1 | Synonyms: | CHROMOPHORE (PHE-CYS-TYR-GLY) | Definition date: | 2006-02-14 | Last modified: | 2024-09-27 | Identifier: | [(4Z)-2-{(2R)-2-[(1S)-1-amino-2-phenylethyl]-2-hydroxy-2,5-dihydro-1,3-thiazol-4-yl}-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl]acetic acid |
|